Related Experiment Video
Updated: May 5, 2026

Targeted DNA Methylation Analysis by Next-generation Sequencing
Published on: February 24, 2015
p16(INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma
Y Matsuda1, T Ichida, J Matsuzawa
1Department of Internal Medicine III, Niigata University School of Medicine, Niigata, Japan.
Background & Aims:
The molecular status of the p16(INK4) tumor-suppressor gene has not been fully elucidated in hepatocellular carcinoma. The aim of this study was to clarify the mechanism that gives rise to inactivation of p16(INK4) in hepatocellular carcinoma.
Methods:
The status of p16(INK4) was evaluated in 60 hepatocellular carcinomas by immunohistochemical staining, differential polymerase chain reaction, single-strand conformational polymorphism, methylation-specific polymerase chain reaction, and methylation-sensitive single nucleotide primer extension.
Results:
Immunohistochemical staining showed that 29 of the 60 tumors exhibited complete loss of p16(INK4) expression. High levels of DNA methylation were detected in 24 of 29 cases of hepatocellular carcinoma with negative p16(INK4) expression, with methylation of 60%-85% of the CpG islands. In contrast, the level of methylation was <25% in tumors with faint p16(INK4) staining, and no methylation was detected in tumors with positive immunostaining. Intragenic alteration of p16(INK4) was detected in 4 cases.
Conclusions:
A strong correlation was found between the extent of methylation and the degree of expression of p16(INK4) in tumor tissues, indicating that epigenetic change due to extensive CpG methylation is the main cause of inactivation of p16(INK4) in hepatocellular carcinoma.
Insights
Epigenetic changes, specifically extensive CpG methylation, are the primary drivers of p16(INK4) gene inactivation in hepatocellular carcinoma. This explains the loss of this tumor-suppressor gene
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- The role of the p16(INK4) tumor-suppressor gene in hepatocellular carcinoma (HCC) remains incompletely understood.
- Investigating the molecular mechanisms behind p16(INK4) inactivation is crucial for understanding HCC development.
Purpose of the Study:
- To elucidate the primary mechanisms responsible for the inactivation of the p16(INK4) gene in hepatocellular carcinoma.
Main Methods:
- Evaluated p16(INK4) status in 60 HCCs using immunohistochemistry, PCR-based methods (differential PCR, SSPyrimidine), and methylation analysis (MSP, MS-SNuPE).
Main Results:
- Complete loss of p16(INK4) expression was observed in 29/60 HCCs.
- Extensive CpG island methylation (60-85%) correlated with absent p16(INK4) expression in 24/29 cases.
- Minimal methylation (<25%) or no methylation was found in tumors with retained p16(INK4) expression; intragenic alterations were rare (4 cases).
Conclusions:
- Epigenetic silencing via extensive CpG methylation is the predominant mechanism for p16(INK4) inactivation in HCC.
- A strong correlation exists between methylation levels and p16(INK4) expression, highlighting its role in HCC pathogenesis.
Related Concept Videos
Epigenetic Regulation
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
DNA Damage Can Stall the Cell Cycle

